Back to Dashboard
Regencell Bioscience Holdings L (RGC)
Real-time intraday values
Market Overview
From:
To:
RGC Intraday
No data available
SymbolRGC
IPO DateJul 16, 2021
CEOMr. Yat-Gai Au
Full Time Employees10
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryHong Kong
ExchangeNasdaqCM
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Performance
| Period | Return % | Value Change |
|---|---|---|
| 1 Day | -3.67% | -0.75 US$ |
| 5 Days | -1.45% | -0.29 US$ |
| 1 Month | -25.24% | -6.65 US$ |
| 6 Months | +18.67% | +3.10 US$ |
Analyzing Market with AI
Evaluating the last 30 days of history and fundamental metrics of RGC...
Key Statistics
Market Cap
9.77B
P/E Ratio
N/A
Div Yield
N/A
52W High
$83.60
52W Low
$9.39
Community Thoughts
Share your analysis and sentiment on RGC
Join the community to share your analysis
Latest News for RGC
RGC Resources Q2 Earnings Call Highlights
MarketBeat•May 8, 2026, 11:05 PM
RGC Resources Inc (RGCO) Q2 2026 Earnings Call Highlights: Strong Income Growth Amid ...
GuruFocus.com•May 9, 2026, 07:04 AM
RGC Resources, Inc. Q2 2026 Earnings Call Summary
Moby•May 8, 2026, 05:02 PM
RGC Resources, Inc. Reports Second Quarter Earnings
GlobeNewswire•May 6, 2026, 08:30 PM
RGC Resources (RGCO) Q2 2026 Earnings Transcript
Motley Fool•May 8, 2026, 02:39 PM
What To Expect From RGC Resources Inc (RGCO) Q2 2026 Earnings
GuruFocus.com•May 7, 2026, 01:19 PM
RGC Resources, Inc. Schedules Second Quarter 2026 Earnings Call
GlobeNewswire•Apr 24, 2026, 08:20 PM
Runway Growth Finance Corp. Reports First Quarter 2026 Financial Results
GlobeNewswire•May 7, 2026, 08:05 PM
RGC Resources, Inc. Declares Quarterly Dividend
GlobeNewswire•Mar 31, 2026, 08:00 PM
Auditor Change Puts Regencell Bioscience Governance And Cash Runway In Focus
Simply Wall St.•Apr 27, 2026, 10:07 AM